[1]
M. Kontić and F. Markovic, “Liquid Biopsy as a Source of Potential Biomarkers for Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer ”, medi, vol. 57, no. 2, May 2024, doi: 10.5937/medi57-46846.